Cargando…
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
INTRODUCTION: Contemporary risk assessment tools categorise patients with pulmonary arterial hypertension (PAH) as low, intermediate or high risk. A minority of patients achieve low risk status with most remaining intermediate risk. Our aim was to validate a four-stratum risk assessment approach cat...
Autores principales: | Boucly, Athénaïs, Weatherald, Jason, Savale, Laurent, de Groote, Pascal, Cottin, Vincent, Prévot, Grégoire, Chaouat, Ari, Picard, François, Horeau-Langlard, Delphine, Bourdin, Arnaud, Jutant, Etienne-Marie, Beurnier, Antoine, Jevnikar, Mitja, Jaïs, Xavier, Simonneau, Gérald, Montani, David, Sitbon, Olivier, Humbert, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245192/ https://www.ncbi.nlm.nih.gov/pubmed/34737227 http://dx.doi.org/10.1183/13993003.02419-2021 |
Ejemplares similares
-
Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017) -
Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021) -
Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021) -
Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022) -
Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)